CollPlant Biotechnologies Ltd.
CLGN
$1.90
$0.3724.18%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | |||
|---|---|---|---|---|---|
| Net Income | 10.36% | -2.76% | -0.36% | ||
| Total Depreciation and Amortization | -5.10% | -2.30% | -6.79% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -24.52% | -23.37% | 47.47% | ||
| Change in Net Operating Assets | -218.18% | 126.06% | -339.27% | ||
| Cash from Operations | -0.46% | 12.22% | -20.75% | ||
| Capital Expenditure | 57.86% | 30.69% | -146.34% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | 100.00% | -- | ||
| Cash from Investing | 58.57% | 45.95% | -215.85% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | -100.00% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -- | -- | -100.00% | ||
| Foreign Exchange rate Adjustments | 53.85% | 133.05% | 4.07% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 2.45% | 17.56% | -24.82% | ||